CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
Max Neeman International is the only CRO in India to manage hemophilia trials according to the Clinical Trials Registry-India (CTRI). Of the total hemophilia trials currently being conducted in India, Max Neeman can boast supporting 80% of these with the remaining conducted by pharma companies.  more Max Neeman International ISO 14155: 2011 Certified for Medical Device Trials
Max Neeman announces the grant of ISO 14155:2011 certificate; the only Indian CRO and one of only a few global CROs to be certified for design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes.  more Max Neeman International Launches Customized Project Management Software for India-based Clinical Studies
Max Neeman International, creates and launches customized Project Management Software (PMS) to meet unique study needs and client demands. The Project Management Software deployed by Max Neeman is a powerful web-based tool that is flexible, dynamic, user-friendly and very easy to access from anywhere. The advantages offered by our PMS software are its ease of study design, set-up, and short implementation   more Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery
Max Neeman International, leading Indian CRO, is part of the prestigious Max Group whose sister-company, Max Healthcare recently had one of 12 hospitals, 'Max Institute of Minimal Access, Metabolic & Bariatric Surgery' accredited as a Center of Excellence (COE) by the Surgical Review Corporation (SRC), USA. The institute has become the first center in India to receive the accreditation.   more Max Neeman International Responds to New India Clinical Research Guidelines
The Drug Controller General of India (DCGI) has formed new Regulatory and ICH GCP guidelines. These guidelines include: recommendations regarding structure and format of genomic biomarker regulatory submissions; the Development Safety Update Report (DSUR), intended to be a common standard for periodic reporting on drugs under development among ICH regions.  more Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study
Current Ph IV success and activities are due to a specific business model Max Neeman created for such 'Observational studies' based on over 10 years of experience. Segments of the business model include: zonal stratification of >1000 sites and SOPs to improve quality of patient data retrieved in large studies. More than 30 CSRs have been developed to date.  more Max Neeman Develops Innovative Approach for Rare Disease Studies
Max Neeman is a leading CRO in India that has a focus on Rare Disease Studies, in addition to other indications. Patient enrollment for rare disease, complex global and multi-centric trials is challenging because potential subjects are fewer in number and widely dispersed.   more Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India
Max Neeman brought together USA and India based renowned group of Neuro and Spinal surgeons from prestigious hospitals across India and USA to form an advisory committee.   more Over 200 Studies Awarded to India-Based CRO Max Neeman International
Max Neeman International, India's premier CRO, has quadrupled the amount of clinical trials awarded since 2007 and reached the milestone of over 200 in 2010. Per CEO, Dr. Ajoy Kumar, "Focused areas of specialty, unique offerings, customer service and consistent growth in response to customer demand, are the cumulative factors which helped us to achieve this number."   more Max Neeman International ISO 27001:2005 Certified for Information Security Management Systems
This updated certification of the world renowned British Standard for Information Security Management Systems (BS 7799-2:2002) is the standard outlining requirements for an Information Security Management System (ISMS). An ISMS helps in designing; implementing and maintaining a set of processes and systems to manage the risk posed to the information assets of an organization.  more Chief Operating Officer of Leading India-based CRO, Max Neeman International Featured as One of Indias Top 10 Women Achievers in Life Sciences Industry
Max Neeman International announced today that Dr. Renu Razdan has been featured in the November issue of BioSpectrum India as a prominent female achiever in the Life Sciences community with valuable guidance as to what it takes to be a leader. Her insighful Q&A interview stresses that "a good work environment is critical for success."  more India's Favorable and Progressive Regulatory Environment Causes Accelerated Growth of Max Neeman International's Regulatory Services
India has evolved into a preferred destination for conducting clinical trials in large part because the Indian Regulatory bodies have created an environment which is focused on quality, transparency and protection in research activities. Regulatory standards meet the requirements of ICH GCP, ICMR (Indian Council of Medical Research) and all the other regulatory bodies across the globe.   more Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
Leading Indian CRO to Improve Management of Endocrinology/Metabolic Disorder   more Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman has formed an experienced and world class team of medical device experts specializing in carrying out cardiac device trials – therapeutic, diagnostic and surgical.  more Max Neeman International Continues to Expand in Response to Increased Client Demand for Medical Writing Services
Max Neeman International, India's premier CRO, has expanded its team of medical writers in response to the growing demand for medical writing services. The team consists of highly qualified medical writers with scientific or medical educations and clinical experience. The expansion now allows for medical writers to be assigned to a project who have the specific therapeutic and document expertise it requires. The newly expanded team works closely with the biostatistics, quality assurance, regulatory and clinical operations groups to better serve the client.  more Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
Max Neeman International, India's premier CRO, created a niche in Data Management services and has extended the platform to provide expert CDISC (Clinical Data Interchange Standards Consortium) services and modified solutions which include on-going and le  more Max Neeman International Sets Up an Exclusive Team for Cosmetic Studies Expanding Upon Dermatology Experience
Max Neeman International, Indias premier CRO, has entered into the cosmetics arena as this industry recognizes the Indian market potential due to favorable changes in the countrys demographics. A dedicated and experienced Max Neeman team has been set-up to conduct cosmetic studies for evaluation and efficacy of products.   more Max Neeman International Expands its Pharmacy Services Facility in Delhi
Max Neeman International, a leading India based Contract Research Organization and subsidiary of the Max India group, expands its Pharmacy services facility in Delhi to over 4000 square feet.  more Max Neeman International Sets Up a New Vertical for Nutraceutical Studies
Max Neeman International, a leading Indian CRO, expands its list of services with the formation of an exclusive team to conduct studies on Nutraceuticals. There is an emerging trend in the Nutraceuticals industry (also known as the “Fast Moving Healthcare Goods”) and India is one of the fastest growing markets because of world class CROs, R&D facilities, qualified human resources and varied raw materials.   more Max Neeman International and AMEDON Collaborate to Increase EDC Performance
Max Neeman International offers additional electronic data management system in collaboration with German software company, AMEDON GmbH for enhanced and expanded Electronic Data Capture (EDC) services.  more Max Neeman International has set up an exclusive team for conducting Minimally Invasive Surgery Studies in collaboration with Max Healthcare.
Max Neeman International, a leading Indian CRO, has formed an exclusive team of ....  more Top Five Pharmaceutical Company Joins with Max Neeman on Groundbreaking Diabetes, Hypertension Prevalence Study
Top Five Pharmaceutical Company Joins with Max Neeman on Groundbreaking Diabetes, Hypertension Prevalence Study   more Max Neeman International Expands its Pharmacy Services facility in Delhi
Max Neeman International, a leading India based Contract Research Organization and subsidiary of the Max India   more Max Neeman to Open Phase I/IIa Unit
Max Neeman, a leading Indian CRO, announced a partnership with Max Healthcare to open a Phase I/IIa clinical trial unit at Max Super Speciality Hospital, New Delhi, India.  more